as 07-26-2024 4:00pm EST
OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.
Founded: | N/A | Country: | United States |
Employees: | N/A | City: | ROCKVILLE |
Market Cap: | 4.0M | IPO Year: | 2015 |
Target Price: | N/A | AVG Volume (30 days): | 12.0K |
Analyst Decision: | Hold | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -31.36 | EPS Growth: | N/A |
52 Week Low/High: | $1.65 - $38.40 | Next Earning Date: | 07-08-2024 |
Revenue: | $2,673,027 | Revenue Growth: | -12.39% |
Revenue Growth (this year): | -22.42% | Revenue Growth (next year): | N/A |
OPGN Breaking Stock News: Dive into OPGN Ticker-Specific Updates for Smart Investing
Business Wire
2 months ago
Business Wire
2 months ago
Newsfile
2 months ago
Business Wire
2 months ago
GlobeNewswire
2 months ago
PR Newswire
2 months ago
PR Newswire
2 months ago
GlobeNewswire
2 months ago
The information presented on this page, "OPGN OpGen Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.